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All foamy viruses give rise to a strong nuclear staining when infected cells are reacted with sera from infected 
hosts. This nuclear ftuorescence distinguishes foamy· viruses from all other retroviruses. · The experiments 
reported here indicate that the foamy virus Gag precursor protein is transiently located in the nuclei of infected 
cells and this is the likely reason for the typical foamy virus nuclear ftuorescence. By using the vaccinia virus 
expression system, a conserved basic sequence motif i~ the nucleocapsid domain of foamy virus Cag proteins 
was identified to be responsible for the nuclear tran$port of the gag precursor molecule. Tbis motif was also 
found to be able to direct a heterologous protein, the Gag protein of human immunodeficiency virus, into the 
nucleus. 
The foamy viruses are a poorly characterized subgroup of 
the family of retroviruses ( 42). Foamy viruses are ubiquitously 
present in simians, felines, and bovines but have only occasion-
ally been found in other mammalian species (17, 18, 28). Their 
natural prevalence among humans isamatter of controversy, 
but aceidentat infections by simian viruses indicate that hu-
mans are susceptible to foamy virus infections (38). The 
pathogenic potential of foamy viruses remains unresolved. 
Whereas mice transgenic for foamy virus genes developed a 
severe encephalopathy and myopathy ( 4 ), natural foamy virus 
infections are believed to result in lifelong persistence and 
infections of an apparently benign nature (17, 18, 28). 
In 1971 the isolation of a foamy virus from human tissue 
(HFV) was reported (1). This foamy virus is the only isolate of 
human origin that is available to the scientific community. 
HFV has been molecularly cloned and sequenced, and infec-
tious molecular clones have been constructed (12, 27, 31, 43, 
44). In addition to gag, pol, and env, foamy viruses possess 
accessory open reading frames (ORF), termed bel, in the 3' 
region of the genome which give rise to two accessory proteins, 
Bel-land Bet (3, 12, 27, 42). Other bel gene-derived proteins 
initially postulated on the basis of PCR mapping of splice sites 
(33) have yet tobe unambiguously identified (3, 42). 
In tissue culture, foamy viruses give rise to extensively 
vacuolated, multinucleated syncytia in a wide range of cells. 
These cells show a strong nuclear staining when they are 
reacted with the sera from foamy virus-infected hosts in an 
immunoftuorescence assay (IFA) (11, 17-19, 28, 29, 39). This 
nuclear ftuorescence is a long-recognized hallmark of foamy 
viruses that has been observed with all virus isolates and all cell 
types that have been studied (17, 18, 28, 50). Since no such 
reaction is observed with any other retrovirus (50), the typical 
nuclear ftuorescence of foamy viruses has been regarded as the 
best criterion for the Serodiagnosis of foamy virus infection 
(38). 
While the accessory Bet protein is localized to the cyto-
plasm, the HFV Bel-l transactivator protein is a nuclear 
protein (3, 21). However, regulatory proteins of retroviruses 
are in generat only required and synthesized in minute 
amounts and give rise to only weak, if any, immuneresponsein 
the infected host (20, 40). By analogy, the cytoplasmic ftuores-
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cence that is observed when human immunodeficiency virus 
(HIV)-infected cells are reacted with sera from infected indi-
viduals, despite two nuclear-localized HIV regulatory proteins 
(7, 20, 40), makes Bel-l an unlikely candidate for the foamy 
virus nuclear ftuorescence. 
· We therefore hypothesized that a structural foamy virus 
protein might be localized to the nuclei of infected cells and 
attempted to analyze the molecular basis of the foamy virus 
nuclear ftuorescence. 
MATERIALS AND METHODS 
Cells and viruses. Diploid human embryonie lung fibroblasts 
(HEL and MRC-5), human glioma cells (U-87), human epi-
theloid cells (HeLa), human osteosarcoma cells (143B), mouse 
fibroblasts (3T3TK-), baby hamster kidney cells (BHK-21), 
and African green monkey kidney cells (Vero) were grown in 
minimal essential medium containing 5 to 10% fetal calf serum 
and antibiotics. HFV (1) and the related chimpanzee foamy 
virus (simian foamy virus type 6 [SFV-6]) (16, 19) were 
propagated on HEL cells and titered by infectious center assay 
as described previously (3). SFV-6 was kindly provided by D. 
Neumann-Haefelin (Freiburg, Germany). Vaccinia virus (VV), 
Copenhagen strain, was a gift of U. Brinckmann (Würzburg, 
Germany) and was grown and titered on Vero cells as previ-
ously described (30). 
Recombinant DNA. All plasmid constructions were per-
formed by standard techniques ( 47). All molecular clones were 
characterized by restriction enzyme analysis and/or DNA 
sequencing of the relevant parts by the dideoxy chain termi-
nation method ( 48). 
The source of all HFV gag fragments inserted into the VV 
transfer vectors was pBgag-1. pBgag-1 covers the complete 
HFV gag gene as a 3.54-kb Mstll fragment derived from the 
infectious HFV clone pHSRV (43) that was inserted into the 
EcoRV site of pBluescript; 2.84-kb Nari-Aftll, 1.97-kb Nari-
Draiii, 1.88-kb Nari-Pvull, 1.63-kb Hhai-Hhai, and 1.50-kb 
Nari-Stui fragments from pBgag-1 were individually inserted 
into the multiple cloning site of the VV transfer vector 
p7.5K131 (kindly provided by A. von Brunn, Munich, Ger-
many) downstream of the 7.5K promoter after the ends were 
ftushed with Klenow enzyme or T4 polymerase where appro-
priate. These plasmids (pVgag-1 to pVgag-5) are depicted in 
Fig. 1. 
The VV transfer plasmid pDK-1 (kindly provided by D. 
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FIG. 1. HFV gag deletion mutants inserted into the VV transfer vector. The 5' HFV genome organization and the gag fragments used for the 
generation of rabbit antisera (gag-1 to gag-3) are shown in the upper part of the figure. The glycine-arginine-rich (GR) boxes (I to III) in the 
proposed nucleocapsid (NC) domain of Gag are indicated. Matrix protein (MA), major capsid protein (CA), protease (PR), and reverse 
transcriptase (RT) are shown. 3' deleted fragments of the HFV genome spanning gag and pol sequences as indicated in the lower part of the figure 
were inserted into p7.5Kl31 downstream of the VV 7.5K promoter. 
Kuritzkes, Denver, Colo.) encodes for the HIV-1 Gagprotein 
(23). pDK-1 was cut at a single Bgfll site after 437 of 500 
codons of the HIV gag gene. Insertion of a double-stranded 
oligonucleotide providing a single Stul site and termination 
codons in all reading frames led to pAWS-1 (Fig. 2). pAWS-2 
to pA WS-9 were generated by blunt end insertion of the 
448-bp Acci-Dralll (pAWS-2), 361-bp Acci-Pvull (pAWS-3), 
304-bp Scai-Dralll (pA WS-4), 144-bp Acci-Scal (pA WS-6), 
161-bp Scai-Styl (pAWS-7), 142-bp Haeiii-Dralll (pAWS-8), 
and 390-bp Sspi-Sspl (pA WS-9) fragments, respectively, into 
the Stul site of pA WS-1 in frame with the HIV gag coding 
sequence. To generate pAWS-5, the HFV gag 192-bp Stui-
Dral and 123-bp Pvuii-Pvull fragments were first subcloned 
into the Smal and EcoRI sites, respectively, of pBluescript, 
giving rise to pBgag-3. Finally, a BamHI-EcoRV fragment 
from pBgag-3 was inserted into Stul-cut pAWS-1. Nucleotide 
sequencing of pA WS-2 to pA WS-9 revealed a continuous 
reading frame covering the HIV gag gene and the HFV gag 
fragments. The pAW5-1 to pA W5-9 plasmids are shown in Fig. 2 
pBgag-4 was derived by insertion of a 257-bp Ncoi-Stul 
fragment of pBgag-1 into the Pstl site of pBluescript via 
blunt-end ligation. The HFV gag 144-bp Acci-Scal, 161-bp 
Scai-Styl, and 142-bp Haeiii-Dralll fragments were individu-
ally cloned into the EcoRV site of pBgag-4 in frame with the 
already inserted HFV gag coding sequence, giving rise to 
pBgag-5 to -7, respectively. Finally, the HFV gag motifs from 
pBgag-4 to -7 were excised as BamHI-Hindlll fragments and 
inserted into the Stul site of pA WS-1 in frame with the HIV 
gag coding sequence, generating pA WS-10 and pA WS-12 to 
pAWS-14, respectively, as shown in Fig. 3. pAWS-11 was 
generated by inserting a 423-bp Ncoi-Scal fragment from 
pBgag-1 into pA WS-1. 
Transfections, indirect immunoftuorescence, and antibod-
ies. Cells were grown on glass slides and infected when near to 
confluency with VV at a multiplicity of infection (MOl) of 
approximately 5 PFU per cell. Virus was allowed to adsorb for 
1 h at 3'rC. After removal of the inoculum and one wash with 
complete minimal essential medium, the cells were transfected 
with the plasmids by using the DOT AP method as described by 
the manufacturer (Boehringer, Mannheim, Germany). In brief, 1 
J.Lg of plasmid DNA was diluted in 30 J.Ll of HBS (20 mM N-
2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid [HEPES], 
15 mM NaCl, [pH 7.4]) in a polystyrene reaction vial. A total 
of 10 J.Ll of the transfection reagent DOTAP (1 mg/ml) was 
diluted separately in 30 J.Ll with HBS. Both solutions were 
mixed and incubated for 10 min at room temperature. After 
addition of 140 J.Ll of minimal essential medium, approximately 
2 X 104 Vero cells were transfected with 100 ng of plasmid 
DNA in a total volume of 20 J.Ll of transfection mixture and 
incubated for 3 to 5 h at 37°C. After the transfection mixture 
was replaced by fresh medium, the cells were further incubated 
for 18 to 20 h. For fixation the cells were washed in phosphate-
buffered saline (PBS) and subsequently treated with 3.5% 
(vol/vol) formaldehydein PBS for 30 min and 0.25% (vol/vol) 
Triton X-100 in PBS for 10 min, bothat room temperature. 
BHK-21 and HEL cells were grown on coverslips and 
infected with HFV or SFV-6 at an MOl of 10. After 2 h for 
virus adsorption, the inoculum was replaced by fresh medium 
which, in some experiments, contained 0.2 J.Lg of actinomycin 
D (Sigma, Munich, Germany) per ml. After time intervals 
ranging from 0 to 96 h postinfection (p.i. ), the cells were fixed 
in cold methanol. 
IFA was carried out by blocking the cells with PBS-3% fetal 
calf serum for 60 to 90 min at 37°C. After incubation with 
rabbit- or mouse-derived first antibody for 60 to 90 min at 
3'rC, the cells were washed twice in PBS-0.25% Tween 20. 
The appropriate fluorescein-conjugated second antibody 
(Dako, Hamburg, Germany) was added for 60 to 90 min at 
37°C. After extensive washing in PBS-Tween, the slides were 
mounted and examined under a Leitz Aristoplan microscope. 
IF A of VV -infected and transfected cells revealed an identical 
staining pattem of all cells transfected with a given plasmid. 
The rabbit antisera gag-1, gag-2, and gag-3, directed against 
the matrix (MA), major capsid (CA), and nucleocapsid (NC) 
domains of the HFV Gag protein (Fig. 1 ), respectively, and 
rt-1, tm-1, bel-l, and bel-2, directed against the reverse tran-
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FIG. 2. Construction of a VV transfer vector expressing the HIV-1 Gagprotein and insertion of HFV gag sequences. An oligonucleotide 
providing a single Stul cloning site was inserted into the unique Bglll restriction site of the HIV -1 Gag protein encoding VV transfer plasmid 
pDK-1. HFV NC fragments covering the GR boxes in all possible combinations (pA WS-2 to pA WS-8) or a control fragment derived from the CA 
domain (pA WS-9) was inserted into the new transfer plasmid such that the HFV gag sequences came in frame with the HIV gag sequences. 
scriptase, the transmembrane, the Bel-l, and the Bet proteins, 
respectively, have been described recently {2, 3, 37). For 
immunoftuorescence, gag and bei antisera were diluted 1:200 
in PB~.l% bovine serum albumin, while the pol and env 
antisera were diluted 1:5 0. To detect HIV -1 Gag protein, a 
mouse monoclonal antibody directed against p24 CA (Dia-
nova, Hamburg, Germany) was used at a 1:40 dilution. The 
human serum which contains antibodies against the HFV Gag, 
Pol, Env, Bel-l, and Bet proteins has already been described 
(36) and was used at a 1:100 dilution. 
Cell fractionation and immunoblot. MRC-5 cells infected 
with HFV at a MOl of 10 for 48 h were separated into 
cytoplasmic and nuclear fractions by a procedure described 
previously (24) with slight modifications. Briefly, the cells were 
washed three times with PBS, overlaid with hypotonic buffer 
{10 mM HEPES, 10 mM NaCI, 1 mM MgCI2, 1 mM phenyl-
methylsulfonyl fluoride, 1 JJ.M pepstatin A, 0.1 JJ.M aprotinin, 
10 JJ.M protease inhibitor E64 (Sigma], pH 6.2) for 15 min. 
After a scraping, the cells were passed 10 times through a 
20-gauge needle. Cytoplasmic and nuclear fractions were 
separated by centrifugation at 1,000 x g for 15 min and at 4°C. 
The pellet (nuclei) was resuspended in a buffer containing 50 
mM Tris-HCI (pH 9.0), 150 mM NaCI, 1% Nonidet P-40, and 
protease inhibitors as described for the hypotonic buffer. The 
protein concentrations were determined with a commercial 
assay (Sigma), and equal amounts of proteins from each 
fraction were separated in a sodium dodecyl sulfate (SDS)-
containing 10% polyacrylamide gel. The gel was semidry 
blotted onto nitrocellulose membrane (Schleicher & Schüll, 
Dassel, Germany), and immunoreaction was carried out with 
the gag-2 antibody as previously described, with the ECL 
chemiluminescence detection system {Amersham, Braun-
schweig, Germany) (3). Control lanes were reacted with a 
mouse monoclonal antibody directed against glyceraldehyde-
3-phosphate dehydrogenase {GAPDH), which was a gift of 
H. J. Degen, Würzburg, Germany. 
RESULTS 
The foamy vinas Gag precursor protein is localized to the 
nuclei of infected cells. The reaction of foamy virus infected 
cells with serum from an infected individual gives rise to a 
bright nuclear staining (Fig. 4A), indicating a nuclear-Iocalized 
immunodominant virus protein. To investigate whether a 
structural foamy virus protein is localized to the nuclei of 
infected cells, proliferating BHK-21 cells were infected at a 
high MOl to analyze the virus protein expression pattern in a 
single round of replication. Under these conditions the cells 
remained viable until signs of degradation became visible by 
light microscopy between 96 and 112 h after infection. Cells 
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FIG. 3. Construction of VV transfer plasmids expressing HIV-HFV hybrid gag sequences to resolve the role of GR box I for the nuclear 
localization of HFV Gag protein. The HFV GR boxes I to III were individually inserted into pAWS-1 together with a fragment from the HFV 
gag sequence that precedes the basic motifs. 
were infected at an MOl of 10, fixed after time intervals 
ranging from 0 to 96 h p.i., and stained with rabbit antisera 
specific for the HFV Gag, Pol, and Env proteins for IF A. Env 
protein was first observed 36 h p.i. and was only detected in the 
cytoplasm of infected cells throughout the observation period 
(Fig. 4H). Polprotein became first detectable at 18 h p.i. and 
was predominantly observed in the cytoplasm (Fig. 4G ). How-
ever, in later stages of infection (between 48 and 72 h p.i.), 
staining with Pol-specific antibody in addition revealed some 
weak nuclear staining in approximately 10% of infected cells 
(data not shown). By contrast, the HFV Gagprotein behaved 
differently from Pol and Env. Gagprotein was first detected 15 
h p.i., when it localized solely to the cytoplasm (Fig. 4C). At 18 
h p.i. gag antiserum began to stain the nuclei. At 48 h p.i., all 
Gag protein was observed in the nuclei of infected cells (Fig. 
40). At 72 h p.i., the nuclear fluorescence began to weaken 
and gag-specific antisera again stained the cytoplasm in ap-
proximately 50% of the infected cells (Fig. 4E). The transient 
nuclear localization of HFV Gag protein was observed with 
rabbit antisera generated against different domains of the HFV 
Gag protein (Fig. 1 ), indicating that newly synthesized Gag 
precursor protein is transported to the nuclei of infected cells. 
This view is supported by an experiment carried out to exclude 
the possibility that Gag protein from virions entering the cells 
gives rise to the nuclear fluorescence. When BHK-21 cells were 
infected at an MOl of 50 in the presence of actinomycin D (0.2 
JLg/ml), no staining with gag antibody was observed at any time 
point p.i. (Fig. 4F). Infection of BHK-21 cells with SFV -6 and 
staining with the cross-reactive -antiserum directed against the 
HFV CA protein (gag-2) revealed the nuclear presence of 
SFV-6 Gag protein (Fig. 4B), demonstrating that different 
foamy virus isolates behave similarly with respect to the Gag 
nuclear localization. When primary human fibroblasts (HEL) 
were used instead of BHK-21 cells in infection experiments, 
HFV Gag protein was again observed in the nuclei of infected 
cells, demonstrating that the nuclear pathway of foamy virus 
Gag protein is not a peculiarity of BHK-21 cells ( data not 
shown). 
Staining of infected cells with bel-l- and bel-2-specific 
antisera revealed a fluorescence pattem already described 
previously (3). Bel-l was the first virus protein to become 
detectable by IFA after 12 h p.i. and localized to the nuclei of 
infected cells. However, at this time, reaction with foamy 
virus-positive primate sera did not show any staining ( data not 
shown), indicating that the immune response against the Bel-l 
regulatory protein is insufficient to give rise to the nuclear 
fluorescence observed with sera from infected individuals as 
shown in Fig. 4A Furthermore, with the appearance of the 
cytoplasrnic Bet protein which is made up of sequences of the 
bel-l and bel-2 ORFs (3, 33) 15 to 24 h p.i., bel-l and bel-2 
antisera stained the cytoplasms of infected cells ( data not shown ). 
To further demoostrate that uncleaved Gag precursor pro-
tein is present in the nuclei, we fractionated cytoplasm from 
nuclei of diploid human fibroblasts (MRC-5) infected for 48 h 
with HFV at an MOl of 10. Equal amounts of protein from 
both fractions were separated by SDS-polyacrylamide gel 
electrophoresis (PAGE) and subjected to immunoblot reac-
tion with gag-2 antiserum directed against CA protein. As 
shown in Fig. 5, the Gag precursor molecules of 70 and 74 kDa 
(2) were easily detected in the nuclear fraction, while they were 
almost undetectable in the cytoplasm, as was the cleaved 
32-kDa CA protein in both fractions (2, 3). Staining with an 
antibody against the cytosolic GAPDH protein was performed 
as a control to ensure that protein was present in the cytoplas-
mic fraction. 
Identification of a NLS in HFV Gag by tbe subtractive 
approach. The foamy virus Gag proteins differ from the 
respective proteins of all other retroviruses in that they do not 
have cysteine-histidine boxes (CH boxes) in their NC domains 
(16, 22, 31, 41). Instead, the proposed foamyvirus NC domains 
harbor three stretches of highly basic glycine-arginine-rich 
boxes (GR boxes) (see Fig. 9). Since positively charged amino 
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FIG. 4. IFA of the subcellular localization offoamy virus structural 
proteins in infected BHK-21 cells. (A, C, D, E, G, and H) Cells were 
infected with HFV at an MOl of 10. Cells were fixed 48 h p.i. and 
reacted with HFV-positive human serum (A); cells were fixed 15 (C), 
48 (D) and 72 (E) h p.i., respectively, and reacted with anti-HFV CA 
(gag-2) rabbit serum; or cells were fixed 48 h p.i. and reacted with 
anti-HFV pol (G) and anti-HFV env (H) rabbit sera. (Band F) Cells 
were reacted with gag-2 antiserum; (B) Cells were infected with the 
chimpanzee foamy virus SFV -6; (F) cells were infected with HFV at a 
MOl of 50 in the presence of actinomycin D and fixed 2 h p.i. 
acid sequences are often found in nuclear localization signals 
(NLS) (14), we investigated this possibility for the HFV Gag 
protein in order to analyze the molecular basis of the foamy 
virus Gag nuclear ftuorescence. To do this, we inserted C-
terminally truncated fragments of the HFV gag gene into a VV 
transfer vector (Fig. 1). When pVgag-1 or -2 harboring the 
three GR boxes was transfected into VV-infected Vero cells 
and subsequently stained with gag antibody in IFA, a strong 
nuclear ftuorescence was observed (Fig. 6B and C), indicating 
that the VV -expressed Gag protein behaved in a manner 
similar to that of the foamy virus-expressed protein. The 
analysis of VV constructs in which the HFV gag gene was 
truncated after each of the GR boxes revealed that the region 
covering GR box II (pVgag-3 in Fig. 1; Fig. 60) is required for 
the nuclear transport of foamy virus Gag protein, since p V-
gag-4 and -5 gave rise only to a cytoplasmic ftuorescence (Fig. 
6E and F). When pVgag-3- and pVgag-4-transfected cells were 
analyzed with HFV -positive human serum, the same ftuores-
cence pattern was observed as was seen in the reaction with gag 
antiserum (Fig. 6G and H). 
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FIG. 5. Uncleaved Gag precursor protein is present in the nuclei of 
foamy virus-infected cells. MRC-5 diploid human fibroblasts were 
infected with HFV at an MOl of 10 for 48 h. Cells were fractionated 
into cytoplasm (C) and nuclei (N), and proteins were separated by 
SOS-PAGE and reacted with antibody directed against HFV CA 
protein (gag-2) in the immunoblot assay. The uncleaved Gag precur-
sors (pr70n~48) are detectable in the nuclear fraction. Control lanes 
were reacted with an antibody against GAPDH. M, molecular mass 
markers (in kilodaltons). 
Confirmation of the NLS by the additive approach. In the 
experiments described above the requirement of GR box II for 
the nuclear localization of HFV Gag protein was shown. To 
confirm that GR box II is also sufficient to serve as a NLS for 
a heterologous protein, we used the following additive ap-
proach. The VV transfer plasmid, pDK-1, encoding for the 
HIV -1 Gag protein, was modified by oligonucleotide linker 
insertion such that HFV gag fragments covering the G R boxes 
could be inserted in frame to the HIV gag coding sequence. 
The new plasmid pA WS-1 (Fig. 2) Iacks the C-terminal 63 
amino acids of the HIV Gag, but it retains the HIV CH boxes. 
Transient transfection of both plasmids, pDK-1 and pAWS-1, 
resulted in HIV -1 Gag protein expression in the cytoplasm 
(Fig. 7A and B). 
As shown in Fig. 2, HFV gag fragments with the GR boxes 
in all possible combinations were introduced into pA WS-1. 
When the resulting plasmids, pA WS-2 to pAWS-9, were 
analyzed for the subcellular localization of the Gag fusion 
proteins, using a p24 monoclonal antibody, all constructs 
harboring the HFV GR box II gave rise to nuclear staining 
(Fig. 7C, D, E, and H). pA WS-8 harboring only GR box III, as 
weil as pA WS-9 harboring a fragment derived from the HFV 
CA coding sequence (Fig. 2}, resulted in the cytoplasmic 
expression of the respective fusion proteins (Fig. 71 and K). 
Curiously, the recombinant Gag protein with GR box I ex-
pressed by pA WS-6 was localized to the nuclei of transfected 
cells and, in particular, to the nucleoli (Fig. 7G), as revealed by 
double-staining experiments with anti-rRNA antibody (data 
not shown). In contrast, pA WS-5, which harbors GR box I in 
addition to box 111 (Fig. 2), led to a cytoplasmic appearance of 
the recombinant Gag protein (Fig. 7F). 
While these experiments demonstrated that GR box II can 
serve as a NLS in a heterologous protein context, the rote of 
box I in nuclear localization of the Gag proteins remained 
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FIG. 6. IFA of the subcellular localization of HFV Gagdeletion 
mutants expressed by VV transfer plasmids. The following plasmid 
DNAs were transfected into VV-infected Vero cells which were 
stained with gag-2 antibody: p7.5Kl31 (A), pVgag-1 (B), pVgag-2 (C), 
pVgag-3 (D), pVgag-4 (E), and pVgag-5 (F). pVgag-3-transfected cells 
(G) and pVgag-4-transfected cells (H) were reacted with human 
HFV-positive serum (36). Nuclear staining was observed only with 
constructs harboriitg GR box II (B, C, D, and G). 
obscure. GR box I, present in the constructs pVgag-4 and 
pA WS-5, was found. to be insufficient to locate HFV Gag 
protein as weH as HIV Gag protein to the nucleus. This finding 
suggested that GR box I does not serve as a NLS in its natural 
context and that the nucleolar accumulation of the Gag protein 
observed with pA WS-6 might be due to the strong RNA-
binding properties of this particular recombinant, similar to 
previous Observations of other systems which averexpress viral 
RNA-binding proteins ( 45). 
To further analyze the contribution of GR box I to the 
nuclear localization of HFV Gag protein, we constructed an 
additional set of recombinants as depicted in Fig. 3. pA WS-10 
harbors a HFV gag fragment preceding the GR boxes which 
was fused to the HIV gag coding sequence. In pA WS-11 to 
pAWS-14, the GR boxes were individually cloned downstream 
of this HIV/HFV hybrid gag gene. The analysis of the subcel-
lular localization of the Gag proteins expressed from these 
constructs revealed that only pA WS-13, which harbors GR box 
II, gave rise to a nuclear fluorescence (Fig. 8C). This result 
indicates that GR box I does not act as a NLS in the context of 
the HFV Gag protein. The use of BHK-21 cells instead of 
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FIG. 7. IFA of the subcellular localization of hybrid HIV-HFV 
Gag proteins with anti-p24 monoclonal antibody. (A) pDK-1; (B) 
pAWS-1; (C) pAWS-2; (D) pAWS-3; (E) pAWS-4; (F) pAWS-5; (G) 
pA WS-6; (H) pA WS-7; (I) pA WS-8; (K) pAWS-9. While the authentic 
HIV Gagprotein was localized to the cytoplasm (A and B), HIV-HFV 
Gag fusion proteins were located in the nucleus if the protein 
contained GR box II (C, D, E, and H). pAWS-5, containing GR boxes 
I and III, led to the cytoplasmic appearance of the fusion protein. 
Transfeetion of pAWS-6 in which only GR box I was C tenninally 
fused to the HIV gag coding sequence resulted in a predominantly 
nucleolar staining. Expression analysis of pAWS-7 transfected into 
1438, HeLa, U87, or 3T3 cells gave identical results, as shown here for 
Vero cells, demonstrating the cell type independence of the foamy 
virus NLS (data not shown). 
Vero cells resulted in an identical staining pattern with all VV 
constructs ( data not shown ). 
DISCUSSION 
The experiments reported here strongly suggest that the 
foamy virus typical nuclear fluorescence that is observed in 
4952 SCHLIEPHAKE AND RETHWILM 
FIG. 8. IFA of the subcellular localization of hybrid HIV-HFV 
Gagproteins in Vero cells. (A) pAWS-10; (B) pAWS-12; (C) pAWS-
13; (D) pAWS-14. Only pAWS-13 (C) expressing a hybrid Gagprotein 
with GR box II gave rise to a nuclear staining, while the other 
constructs led to the cytoplasmic accumulation of the fusion proteins. 
pAWS-11 gave results identical to those ofpAWS-12 (data not shown). 
The cytoplasmic fluorescence observed with constructs pA WS-11 and 
pAWS-12 (B) indicated that GR box I does not serve as a NLS in its 
natural protein context. 
IF A with sera from infected hosts is due to an antibody 
response against Gag antigen. The Gag protein precursor of 
foamy viruses was found to be transiently located in the nuclei 
of infected cells. By using the W expression system, a basic 
region (GR box II) in the proposed NC domain of foamy virus 
Gag proteins was identified to be responsible for directing the 
Gag precursor protein into the nuclei of infected cells. Fur-
thermore, GR box II was able to translocate a heterologous 
retroviral Gag precursor protein which is normally found only 
in the cytoplasm into the nucleus. 
In foamy viruses the Gag proteins show a higher degree of 
genetic divergence than the other structural proteins (16, 22, 
31, 41). Alignment of the deduced NC sequences of four 
primate foamy virus isolates revealed a high degree of conser-
vation of the three GR boxes, with GR box II being almost 
perfectly conserved, underlining the importance of this motif 
(Fig. 9). Furthermore, the primary structure of GR box II 
shows close similarities to NLS known from other proteins (for 
a review, see reference 14). 
The Iack of CH boxes, the conservation of the GR box II, 
and the Observation that nuclear localization of Gag is a 
common feature of all foamy viruses investigated so far are 
suggestive of a specific function of the nuclear pathway of 
foamy virus Gag precursors in the virus replication cycle. 
However, at the moment one can only speculate on these 
possible functions. 
Nuclear localization of retroviral Gag proteins in HIV has 
been described {5, 6, 49). In this case the MA protein is 
believed to direct the nucleoprotein complex, after the uncoat-
ing of the virus, to the nucleus to deliver the cDNA (5, 6, 49). 
This finding for HIV is clearly different from that reported 
here because the nuclear translocation of foamy virus Gag 
protein takes place after synthesis and affects the Gag precur-
sor. 
Also, the nuclear localization of the foamy virus Gag pre-
cursor does not seem to be simply a side effect of unspecific 
RNA-binding properties of the protein. To our knowledge, no 
other retrovirus transports its Gag precursor quantitatively to 
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FIG. 9. Comparison of the C-terminal Gag sequences derived from 
four different primate foamy viruses demonstrates the conservation of 
GR box II. Foamy virus Gag sequences (16, 22, 31, 41) from HFV, 
SFV-1, SFV-3, and from a foamy virus isolated from a chimpanzee 
(SFVcpz) were aligned by using the Megaline program (DNASTAR). 
The GR boxes are indicated. GR box II harbors the NLS. 
the nucleus, although all retroviral Gag proteins bind RNA 
(50, 53). The cytoplasmic localization of VV-expressed HIV 
Gag protein (Fig. 7A) and the nuclear localization of W-
expressed HFV Gagprotein described in this study (Fig. 6B) 
illustrate this fundamental difference. Unspecific nuclear local-
ization may be the case with construct pA WS-6, in which the 
GR box I was fused C terminally to the HIV-1 Gag protein. 
The results obtained with plasmids pVgag-4, pAWS-5, pAWS-
11, and pAWS-12 indicate that GR box I does not serve as a 
NLS in its natural protein context. The effect of the protein 
context on the function of a NLS has also been described for 
the simian virus 40 large T nuclear signal (46). However, GR 
box I may have an enhancing effect on the nuclear transport of 
the HFV Gag precursor protein similar to that of HBV core 
protein (10). 
A variety of hypotheses may explain the nuclear pathway of 
the foamy virus Gag precursor, each having arguments for and 
against. 
The primary structure of foamy virus NC domains is remi-
niscent of the dass of arginine-rieb RNA-binding proteins (25) 
and the C-terminal basic motif of hepatitis B virus (HBV) core 
protein {10, 34, 35). With respect to HBV, it is noteworthy that 
the core protein is localized, at least in part, to the nuclei of 
infected cells (10, 13, 35). It is believed that HBV core particles 
perform an intracellular replication cycle. This replicative 
shortcut was suggested to result in the accumulation of HBV 
DNA in the infected cell (13, 35, 52). Large amounts of 
unintegrated DNA have also been reported for foamy viruses 
(32). It remains to be seen whether or not this finding can be 
attributed to a similar mechanism, as hypothesized for HBV. 
In general, large amounts of unintegrated DNA in retrovirus-
infected cells are believed to result from superinfection (51). 
Packaging of retroviral genomic RNA occurs in the cyto-
plasm (26, 53). The Iack of the otherwise conserved CH boxes 
in the NC domain and the presence of the GR boxes are 
indicative of a different mechanism of RNA packaging in 
foamy viruses compared with that in other retroviruses (26, 
53). Assuming that the GR boxestake over the role of the CH 
boxes in packaging, this may involve the pickup of the genomic 
RNA in the nucleus. The transiency of the nuclear-localized 
VoL. 68, 1994 
foamy virus Gag precursor protein is a strong argument for this 
hypothesis. In this case one might expect foamy virus core 
particles to assemble in the nucleus. Nuclear-localized core 
structures have been occasionally observed in SFV -1- and 
BFV-infected cells by electr'on microscopy (8, 9). However, the 
nuclear presence of core particles is not a general character-
istic of foamy viruses, and immature viral cores are easily 
observed in the cytoplasms of infected cells (15). 
Finally, one may consider a regulatory function for foamy 
virus Gag proteins. In contrast to other complex retroviruses, a 
posttranscriptionally acting regulatory protein that directs the 
expression of structural proteins in foamy viruses has not been 
identified (42). We therefore cannot exclude that the foamy 
virus Gagprotein acts as a positive regulatory of the expression 
of the genomic RNA. However, previous studies indicate that 
there is no evidence for such a mechanism in foamy viruses (3). 
Future experiments will have to clarify whether or not the 
nuclear pathway of the Gag precursor is essential for foamy 
virus replication and what its specific function is. 
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